No doubt, a strong portfolio typically includes stocks with robust fundamentals and solid track records. In a bull market, these investments provide healthy returns and protect against capital erosion. However, we should not overlook the benefits of owning penny stocks, either. The get-rich-quick angle with these picks is a real possibility. That’s why they continue to garner investor interest.
That said, penny stocks can also be a double-edged sword. Naturally, everyone is attracted to the low price tag. But it’s extremely important to understand which stocks are trading at a bargain and which ones are trading cheaply. The former can have real potential to super-charge your portfolio.
With the retail-trading frenzy we’ve seen this year, it seems like it doesn’t take much to move the needle for these low-priced picks. This is due in part to highly active social media forums who closely follow the sector, such as Reddit’s r/WallStreetBets. Ultimately, though, everyone is looking for massive profits from their investments.
Hot Low Price Stocks To Watch Right Now: Merit Medical Systems Inc.(MMSI)
Merit Medical Systems, Inc. designs, develops, manufactures, and markets medical devices for use in interventional and diagnostic procedures worldwide. It offers cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease, and other non-vascular diseases. The company?s cardiology and radiology devices include inflation devices; hemostasis valves; vascular retrieval devices; vascular access products; diagnostic catheters; guide wires and torque devices; and angiography and angioplasty accessories. Its cardiology and radiology devices also comprise safety and waste management systems; radial artery compression devices; drainage catheters and accessories; paracentesis, thoracentesis, and pericardiocentesis catheters; therapeutic infusion catheters; embolic microspheres; multipurpose microcatheters; and dialysis and interventional nephrology products. The company also provides gastroenterology and pulmonolog y devices that assist in the palliative treatment of expanding esophageal, tracheobronchial, and biliary strictures caused by malignant tumors. Its gastroenterology and pulmonology devices consist of airway, esophageal, and biliary stents; stent sizing devices; guide wires for non-vascular procedures; bipolar coagulation probes; inflation devices; and cholangiography rapid refill continuous injection kits, as well as specialty devices and accessories, such as discography products and pressure sensors. The company sells its products through direct sales force, distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. Its customers include hospitals and clinic-based cardiologists, radiologists, anesthesiologists, physiatrists, neurologists, nephrologists, vascular surgeons, interventional gastroenterologists and pulmonologists, thoracic surgeons, technicians, and nurses. Merit Medical Systems, Inc. was founded in 1987 and is headquartered in South Jordan, Utah.
Advisors’ Opinion:
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Merit Medical Systems (MMSI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Motley Fool Transcribers]
Merit Medical Systems Inc (NASDAQ:MMSI)Q4 2018 Earnings Conference CallFeb. 26, 2019, 5:00 p.m. ET
Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:
Operator
- [By Ethan Ryder]
Merit Medical Systems (NASDAQ:MMSI) issued an update on its FY 2019 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $1.97-2.08 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.97. The company issued revenue guidance of $1.011-1.03 billion, compared to the consensus revenue estimate of $1.01 billion.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Merit Medical Systems (MMSI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Hot Low Price Stocks To Watch Right Now: GRAVITY Co. Ltd.(GRVY)
Gravity Co., Ltd. engages in the development and publishing of online games in Japan, Taiwan, Brazil, the Philippines, Indonesia, Singapore, Malaysia, Thailand, and the Russian Federation. It offers massively multiplayer online role playing games, casual online games, social network games, mobile games, and animation and character-based merchandise, as well as multiplatform and Internet protocol television games. The company?s principal product includes Ragnarok Online, an action adventure-based multiplayer online role playing game that combines cartoon-like characters, community-oriented themes, and combat features enabling various players to interact with one another. Its other multiplayer online role playing games comprise R.O.S.E. Online, Requiem, and Emil Chronicle Online. The company also licenses the merchandizing rights of character-related products based on its online games. In addition, it provides the animation series of Ragnarok Online in DVD and video on dema nd formats, as well as broadcasts these series on televisions. Further, the company, along with its licensees, markets dolls, stationery, and other character-based merchandise, as well as game manuals, monthly magazines, and other publications. Additionally, it offers Pororo Game, an Internet protocol television game. The company was founded in 2000 and is based in Seoul, Korea. As of December 31, 2010, Gravity Co., Ltd. operates as a subsidiary of GungHo Online Entertainment, Inc.
Advisors’ Opinion:
- [By Joseph Griffin]
BidaskClub upgraded shares of Gravity (NASDAQ:GRVY) from a strong sell rating to a sell rating in a research note issued to investors on Tuesday morning.
- [By Max Byerly]
ILLEGAL ACTIVITY WARNING: “Gravity (GRVY) Receives Coverage Optimism Score of 0.17” was first published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another publication, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be viewed at www.tickerreport.com/banking-finance/3382037/gravity-grvy-receives-coverage-optimism-score-of-0-17.html.
Hot Low Price Stocks To Watch Right Now: Aerohive Networks, Inc.(HIVE)
Aerohive Networks, Inc. and together with its subsidiaries (“Aerohive Networks,” “Aerohive,” “Company,” “we,” “us,” and “our”) has designed and developed a leading cloud networking and enterprise Wi-Fi solution that enables our customers to use the power of Wi-Fi, cloud, analytics and applications to transform how they serve their customers. Our products include Wi-Fi access points, routers and switches required to build an edge-access network; a cloud services platform for centralized management, data collection and analytics; and applications that leverage the network to provide additional capabilities to the business and IT organization. Together, these products, service platforms and applications create a simple, scalable, and secure solution to deliver a better connected experience. Customers around the world, from Fortune 500 businesses to small schools, have chosen our products. Advisors’ Opinion:
- [By ]
Our Biggest Loser… And A Bunch Of Big Wins
Our biggest loser was back in January when we closed out of small communications equipment firm Aerohive Networks (Nasdaq: HIVE). On January 17, the company made a statement about its upcoming fourth-quarter earnings release, warning that revenue would likely be near the lower end of its guidance range. Investors didn’t take kindly to the news and sent shares tumbling by roughly 30%… well below our 15% trailing stop-loss. We ended up closing out with a 35% loss on the trade. - [By Max Byerly]
Leidos (NYSE: LDOS) and Aerohive Networks (NYSE:HIVE) are both aerospace companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends.
- [By Logan Wallace]
Aerohive Networks Inc (NYSE:HIVE) was the target of a significant drop in short interest in the month of June. As of June 15th, there was short interest totalling 573,420 shares, a drop of 35.3% from the May 31st total of 885,671 shares. Based on an average trading volume of 381,201 shares, the days-to-cover ratio is currently 1.5 days. Approximately 1.8% of the shares of the stock are short sold.
- [By Stephan Byrd]
Here are some of the news articles that may have effected Accern’s rankings:
Get Anthera Pharmaceuticals alerts:
Cystic Fibrosis Drugs Market – Future Growth Prospects and Industry Trends Analyzed Till 2025 (digitaljournal.com) Analysts Anticipate Anthera Pharmaceuticals Inc (ANTH) Will Announce Earnings of -$0.60 Per Share (americanbankingnews.com) News Buzz : Blink Charging Co. (NASDAQ:BLNK), Genocea Biosciences, Inc. (NASDAQ:GNCA), Anthera … (journalfinance.net) Current Lumpy Stocks:: Jounce Therapeutics, Inc. (NASDAQ:JNCE), Aerohive Networks, Inc. (NYSE:HIVE), Anthera … (journalfinance.net) Porous, non-porous tantalum cups yielded similar septic, aseptic risks after revision THA (healio.com)
ANTH has been the topic of a number of research analyst reports. Zacks Investment Research upgraded Anthera Pharmaceuticals from a “hold” rating to a “buy” rating and set a $1.75 target price on the stock in a research report on Tuesday, February 13th. Jefferies Financial Group reiterated a “hold” rating and set a $0.50 target price on shares of Anthera Pharmaceuticals in a research report on Thursday, March 15th. Roth Capital initiated coverage on Anthera Pharmaceuticals in a research report on Wednesday, February 21st. They set a “buy” rating and a $10.00 target price on the stock. Finally, Piper Jaffray Companies downgraded Anthera Pharmaceuticals from an “overweight” rating to an “underweight” rating in a research report on Monday, March 12th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $3.44.
Hot Low Price Stocks To Watch Right Now: Johnson Controls Inc.(JCI)
Johnson Controls, Inc. engages in building efficiency, automotive experience, and power solutions businesses worldwide. Its building efficiency business designs, produces, markets, and installs integrated heating, ventilating, and air conditioning systems, as well as building management systems, controls, and security and mechanical equipment. This business also provides technical services, energy management consulting, and operations of real estate portfolios for the non-residential buildings market. In addition, this business offers residential air conditioning and heating systems, and industrial refrigeration products. The company?s automotive experience business designs and manufactures interior products and systems for passenger cars and light trucks, including vans, pick-up trucks, and sport/crossover utility vehicles. It offers seating systems and components; cockpit systems comprising instrument panels and clusters, information displays, and body controllers; overh ead systems, such as headliners and electronic convenience features; floor consoles; and door systems. This business also produces automotive interior systems for original equipment manufacturers. Its power solutions business produces lead-acid automotive batteries serving automotive original equipment manufacturers and the general vehicle battery aftermarket. This business produces lead-acid batteries, as well as offers absorbent glass mat and lithium-ion battery technologies to power hybrid vehicles. The company was formerly known as Johnson Electric Service Company and changed its name to Johnson Controls, Inc. in 1974. Johnson Controls, Inc. was founded in 1885 and is headquartered in Milwaukee, Wisconsin.
Advisors’ Opinion:
- [By ]
Johnson Controls International (NYSE:JCI) had its price objective increased by Royal Bank of Canada from $70.00 to $76.00 in a research report sent to investors on Thursday morning, The Fly reports. Royal Bank of Canada currently has a sector perform rating on the stock.
- [By Max Byerly]
Commonwealth Equity Services LLC cut its holdings in Johnson Controls International PLC (NYSE:JCI) by 32.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 91,206 shares of the company’s stock after selling 43,598 shares during the period. Commonwealth Equity Services LLC’s holdings in Johnson Controls International were worth $2,704,000 at the end of the most recent reporting period.
- [By Lou Whiteman]
Should UTC explore this path, a merger with Johnson Controls (NYSE:JCI) appears the most likely option. In December, I estimated Carrier’s stand-alone value would be about $30 billion, which is about Johnson Controls’ market capitalization. And the two HVAC businesses have similar earnings from HVAC and building controls as well.
Hot Low Price Stocks To Watch Right Now: Accuray Incorporated(ARAY)
Accuray Incorporated designs, develops, and sells medical radiation systems for the treatment of tumors anywhere in the body. The company offers the CyberKnife system, an image-guided robotic radiosurgery system used for the treatment of solid tumors. The system tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation typically with sub-millimeter accuracy. The company also offers the TomoTherapy system, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. Accuray Incorporated markets its product through a direct sales force and distributors worldwide. The company was incorporated in 1990 and is headquartered in Sunnyvale, California.
Advisors’ Opinion:
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Accuray (ARAY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Ethan Ryder]
Shares of Accuray Incorporated (NASDAQ:ARAY) shot up 5.1% during trading on Friday . The stock traded as high as $4.15 and last traded at $4.10. 2,319,305 shares changed hands during mid-day trading, an increase of 254% from the average session volume of 655,530 shares. The stock had previously closed at $3.90.
- [By Max Byerly]
Get a free copy of the Zacks research report on Accuray (ARAY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Hot Low Price Stocks To Watch Right Now: Inovio Pharmaceuticals, Inc.(INO)
Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. Its SynCon immunotherapy design has the ability to break the immune systems tolerance of cancerous cells; and SynCon product design is also intended to facilitate cross-strain protection against known, as well as new unmatched strains of pathogens, such as influenza. It has completed, current or planned clinical programs of its proprietary SynCon immunotherapies for HPV-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus, hepatitis B virus, HIV, Ebola, Middle East Respiratory Syndrome, and Zika virus. The company has collaborative development agreements with GeneOne Life Sciences to co-develop an Ebola vaccine through Phase I clinical trials; and The Wistar Institute for preventive and therapeutic DNA-based immunotherapy applications, as well as products for cancers and infectious diseases. Inovio Pharmaceuticals, Inc. was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.
